Pacific Biosciences of California (PACB) — Financial Flexibility Index
Pacific Biosciences of California (PACB) has a Financial Flexibility Index of -0.06x as of March 2026. Free cash flow of $-41.65 Million (operating CF $-44.69 Million minus capex $3.04 Million) represents 0% of total liabilities ($677.60 Million). Also explore PACB year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Pacific Biosciences of California Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Pacific Biosciences of California across 18 annual periods. Check PACB strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Pacific Biosciences of California (2008–2025)
Year-by-year free cash flow to debt coverage for Pacific Biosciences of California. For the full company profile including market capitalisation, see PACB company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.14x | $-108.50 Million | $-111.21 Million | $778.73 Million | ▲ +47.5% |
| 2024 | -0.27x | $-199.87 Million | $-206.06 Million | $753.85 Million | ▼ -7.5% |
| 2023 | -0.25x | $-257.70 Million | $-266.55 Million | $1.04 Billion | ▼ -20.6% |
| 2022 | -0.20x | $-246.28 Million | $-263.21 Million | $1.20 Billion | ▼ -136.3% |
| 2021 | -0.09x | $-105.25 Million | $-111.18 Million | $1.22 Billion | ▼ -133.1% |
| 2020 | 0.26x | $20.54 Million | $19.50 Million | $78.49 Million | ▲ +132.3% |
| 2019 | -0.81x | $-75.48 Million | $-78.31 Million | $93.07 Million | ▲ +29.4% |
| 2018 | -1.15x | $-64.58 Million | $-66.43 Million | $56.21 Million | ▼ -16.7% |
| 2017 | -0.98x | $-57.09 Million | $-67.52 Million | $57.98 Million | ▲ +12.3% |
| 2016 | -1.12x | $-59.72 Million | $-67.93 Million | $53.22 Million | ▼ -44.0% |
| 2015 | -0.78x | $-44.88 Million | $-47.89 Million | $57.57 Million | ▼ -8.8% |
| 2014 | -0.72x | $-49.86 Million | $-51.47 Million | $69.57 Million | ▼ -66.0% |
| 2013 | -0.43x | $-28.92 Million | $-29.83 Million | $67.00 Million | ▲ +88.3% |
| 2012 | -3.70x | $-75.12 Million | $-76.82 Million | $20.30 Million | ▼ -6.1% |
| 2011 | -3.49x | $-93.69 Million | $-102.97 Million | $26.85 Million | ▲ +22.6% |
| 2010 | -4.51x | $-116.74 Million | $-122.00 Million | $25.88 Million | ▼ -1701.5% |
| 2009 | -0.25x | $-69.66 Million | $-74.84 Million | $278.22 Million | ▼ -58.6% |
| 2008 | -0.16x | $-32.60 Million | $-38.30 Million | $206.50 Million | — |